| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 901,000 | 911,000 | 1,226,000 | 1,132,000 | | Cost of Revenue | 591,000 | 428,000 | 558,000 | 544,000 | | | Gross Profit | 310,000 | 483,000 | 668,000 | 588,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 135,000 | 294,000 | 372,000 | 371,000 | | Non Recurring | 43,000 | 1,471,000 | 6,000 |
-
| | Others | 43,000 | 47,000 | 47,000 | 46,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 89,000 | (1,329,000) | 243,000 | 171,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | 6,000 | 7,000 | 6,000 | | Earnings Before Interest And Taxes | 93,000 | (1,323,000) | 250,000 | 177,000 | | Interest Expense | 19,000 | 21,000 | 22,000 | 18,000 | | Income Before Tax | 74,000 | (1,344,000) | 228,000 | 159,000 | | Income Tax Expense | 29,000 | 12,000 | 86,000 | 61,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 45,000 | (1,356,000) | 142,000 | 98,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 45,000 | (1,356,000) | 142,000 | 98,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $45,000 | ($1,356,000) | $142,000 | $98,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
